4//SEC Filing
TAYMANS JILL M 4
Accession 0001193125-26-009067
CIK 0000862692other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:00 PM ET
Size
15.2 KB
Accession
0001193125-26-009067
Insider Transaction Report
Form 4
TAYMANS JILL M
VP Finance, CFO
Transactions
- Award
Stock Option
2026-01-07$3.54/sh+10,000$35,400→ 10,000 totalExercise: $3.54From: 2026-01-07Exp: 2031-01-07→ Common Stock (10,000 underlying) - Award
Stock Option
2026-01-07$3.54/sh+20,000$70,800→ 20,000 totalExercise: $3.54From: 2026-01-07Exp: 2031-01-07→ Common Stock (20,000 underlying)
Holdings
- 45,396
Common Stock
- 7,500
Stock Option
Exercise: $3.10From: 2019-06-02Exp: 2026-06-02→ Common Stock (7,500 underlying) - 7,000
Stock Option
Exercise: $8.00From: 2020-09-23Exp: 2027-09-23→ Common Stock (7,000 underlying) - 20,000
Stock Option
Exercise: $4.62From: 2023-01-13Exp: 2028-01-13→ Common Stock (20,000 underlying) - 10,000
Stock Option
Exercise: $5.88From: 2023-12-22Exp: 2028-12-22→ Common Stock (10,000 underlying) - 10,000
Stock Option
Exercise: $7.35From: 2025-01-21Exp: 2030-01-21→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]Stock options vest 1/5 per year commencing on September 23, 2020.
- [F2]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- [F3]Stock options vest 1/3 upon issuance, 1/3 on January 22, 2026 and 1/3 on January 22, 2027.
- [F4]Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
- [F5]The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001261283
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:00 PM ET
- Size
- 15.2 KB